Champions Oncology (CSBR) Stock Delivers Strong Quarterly Improvement

Champions Oncology (CSBR) is continuing on its growth initiative, delivering another set of strong quarterly results, driving both revenue and client bookings higher, with increases of 40% and 30%, respectively. Our partners at Trade Ideas provided the first alert. The CSBR Numbers During the Third Quarter, CSBR revenue increased to $3.6 million dollars, a 40% … Read more

Champions Oncology (CSBR) Stock Fortifies Existing TumorBank

Champions Oncology Inc (NASDAQ: CSBR) Champions Oncology, on Thursday, announced that the company has added new cohorts of PDX models to their existing TumorBank. These new models will expand CSBR’s product line in hepatocellular cancer, breast cancer, castrate resistant prostate cancer, head and neck cancer, AML, and non-small cell lung cancer PDX models. With the … Read more

Champions Oncology (CSBR) Delivers A Profit And Strong Guidance

Champions Oncology(CSBR) delivered a strong earnings message to investors after the market close on Tuesday, letting them know that not only has the company become profitable, they intend to keep it that way going forward. While many of the recent conference call’s that I have listened to during the past two quarters have been positive, … Read more